Journal
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 56, Issue -, Pages 263-267Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2016.10.018
Keywords
Preventive vaccine; Therapeutic vaccine; Pre-exposure vaccine; Post-exposure vaccine; Subunit vaccine; Whole-cell vaccine
Categories
Funding
- The European Union [HEALTH-F4-2011-280873]
- EU Horizon 2020 [643381]
- Bill & Melinda Gates Foundation (BMGF) [GC6-2013, OPP 1055806, OPP 1065330]
- Bundesministerium fur Bildung und Forschung (BMBF)
- Global Health Innovative Technology Fund [G2015147]
- US National Institutes of Health [D43-TW006807]
Ask authors/readers for more resources
Tuberculosis (TB) remains the deadliest infectious disease. The widely used bacille Calmette-Guerin (BCG) vaccine offers only limited protection against TB. New vaccine candidates for TB include subunit vaccines and inactivated whole-cell vaccines, as well as live mycobacterial vaccines. Current developments in TB vaccines are summarized in this review. (C) 2016 The Authors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
